First Day Trading a Letdown for LianBio in Shadow of Beijing Market Crackdown

Monday was a big day for LianBio, as the Shanghai-based company launched on the Nasdaq with an impressive $325 million initial public offering (IPO). However, the initial market result was less thrilling as the stock fell 14% in its U.S. trading debut.